← Evidence map

ReviewHematology/oncology clinics of North America2022

Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms.

Ingo K Mellinghoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34711457